WGRX Wellgistics Health, Inc.
Price Chart
Executive Summary
Wellgistics Health raised $21.1M in a PIPE convertible note offering (net proceeds ~$16.9M after original issue discount) with attached warrants, while simultaneously executing a material agreement to acquire drone/biometric IP and form DelivMeds AI. The massive dilution from the convertible notes and warrants, combined with the company's $9M market cap and prior executive departure, creates a highly dilutive capital structure that overwhelms any strategic upside from the acquisition.
Key Financial Metrics
Actionable Insight
Massive dilutive financing at a $9M market cap company with prior executive departure signals severe financial distress. Monitor for stockholder approval vote (required within ~20 days) and potential Nasdaq delisting if reverse split fails. The mandatory exercise trigger on warrants at $7.50/share (125% of current price) creates a ceiling — any rally toward that level will be met with warrant exercise and further dilution. Avoid long positions until capital structure stabilizes.
Key Facts
- Company raised $21,132,812.50 aggregate principal amount of convertible notes (net proceeds $16,906,250 after original issue discount)
- Investors receive PIPE warrants to purchase 150% of initial principal amount at $7.50/share (125% of closing price), with mandatory exercise trigger at 150% of exercise price
- Placement agent Dawson James receives 3% cash fee ($507k) and 5-year warrants for 12% of shares issuable upon conversion at $6.25/share
- Existing public shareholders diluted to ~10.4% post-conversion of Acquisition Preferred per prior cross-filing
- Company must seek stockholder approval for issuance above 19.99% Exchange Cap (Nasdaq Rule 5635(d))
- Convertible notes include 9.99% beneficial ownership limitation per holder
- Company filed reverse stock split (1-for-50) to regain Nasdaq compliance per prior cross-filing
- Market cap is only ~$9M, making the $21.1M note offering ~234% of market cap
- Prior CEO departure (8-K filed 8 days ago) signals forced management transition
Financial Impact
Convertible note offering of $21.1M principal ($16.9M net) represents ~234% of current $9M market cap. Potential dilution from conversion and warrants could exceed 10x current shares outstanding.
Risk Factors
- Extreme dilution: convertible notes and warrants could increase share count by 10x+
- Nasdaq delisting risk if reverse stock split fails to regain compliance
- Stockholder approval required for issuance above 19.99% Exchange Cap — failure would limit conversion
- Mandatory exercise trigger on warrants creates overhang at $7.50/share
- Prior CEO departure suggests internal turmoil and forced management transition
- Company has $4B asset value claim from acquisition but no financing certainty
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-026452 |
| Exhibit: ex10-2.htm | 0001493152-26-026452 |
| Exhibit: ex10-3.htm | 0001493152-26-026452 |
| Exhibit: ex4-2.htm | 0001493152-26-026452 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 29, 2026
16d ago
|
8-K
| $3.85 $4.35 | ▼ −12.99% | ▼ −15.74% | $3.48 (+9.61%) |
|
May 21, 2026
24d ago
|
8-K
| $5.35 $3.72 | ▼ −30.47% | ▼ −32.07% | $3.48 (−34.95%) |
|
May 19, 2026
26d ago
|
8-K
| $6.45 $3.16 | ▼ −51.01% | ▼ −52.25% | $3.48 (−46.05%) |
|
May 19, 2026
26d ago
|
8-K
| $8.40 $3.22 | ▼ −61.67% | ▼ −63.91% | $3.48 (−58.57%) |
|
May 18, 2026
27d ago
|
8-K
| $8.70 $3.82 | ▼ −56.09% | ▼ −57.71% | $3.48 (−60.00%) |
|
May 8, 2026
5w ago
|
EFFECT
| $4.21 $4.18 | ▲ +0.83% | ▲ +1.04% | $3.48 (+17.34%) |
|
Apr 24, 2026
7w ago
|
10-K/A
| $6.23 $5.20 | ▲ +16.53% | ▲ +16.93% | $3.48 (+44.14%) |
|
Apr 17, 2026
8w ago
|
8-K
| $6.60 $6.23 | ▼ −5.61% | ▼ −6.52% | $3.48 (−47.27%) |
|
Apr 15, 2026
8w ago
|
S-3
| $7.37 $6.79 | ▼ −7.88% | ▼ −8.86% | $3.48 (−52.75%) |
|
Apr 10, 2026
9w ago
|
3
| $6.00 $7.20 | ▲ +20.00% | ▲ +15.50% | $3.48 (−42.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access